Nanosonics 将来の成長

Future 基準チェック /46

Nanosonics利益と収益がそれぞれ年間24%と8.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に11.2% 23.8%なると予測されています。

主要情報

24.0%

収益成長率

23.8%

EPS成長率

Medical Equipment 収益成長	16.2%
収益成長率	8.7%
将来の株主資本利益率	11.2%
アナリストカバレッジ	Good
最終更新日	12 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

CHIA:NAN - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2027	227	28	28	36	9
6/30/2026	208	18	19	24	10
6/30/2025	188	13	14	18	10
6/30/2024	170	13	20	23	N/A
3/31/2024	167	14	21	23	N/A
12/31/2023	164	16	22	24	N/A
9/30/2023	165	18	21	24	N/A
6/30/2023	166	20	20	23	N/A
3/31/2023	154	15	15	20	N/A
12/31/2022	141	10	10	16	N/A
9/30/2022	131	7	5	11	N/A
6/30/2022	120	4	0	7	N/A
3/31/2022	120	7	2	7	N/A
12/31/2021	121	11	4	8	N/A
9/30/2021	112	10	5	8	N/A
6/30/2021	103	9	6	7	N/A
3/31/2021	99	7	7	9	N/A
12/31/2020	95	6	8	10	N/A
9/30/2020	97	8	15	16	N/A
6/30/2020	100	10	21	23	N/A
3/31/2020	96	11	16	18	N/A
12/31/2019	92	12	11	13	N/A
9/30/2019	88	13	7	9	N/A
6/30/2019	84	14	3	5	N/A
3/31/2019	78	12	3	6	N/A
12/31/2018	71	11	4	6	N/A
9/30/2018	66	8	5	8	N/A
6/30/2018	61	6	6	9	N/A
3/31/2018	61	6	N/A	11	N/A
12/31/2017	61	6	N/A	13	N/A
9/30/2017	64	16	N/A	15	N/A
6/30/2017	68	26	N/A	16	N/A
3/31/2017	65	26	N/A	16	N/A
12/31/2016	63	25	N/A	16	N/A
9/30/2016	53	13	N/A	10	N/A
6/30/2016	43	0	N/A	3	N/A
3/31/2016	33	-5	N/A	-3	N/A
12/31/2015	23	-10	N/A	-8	N/A
9/30/2015	23	-8	N/A	-5	N/A
6/30/2015	22	-5	N/A	-2	N/A
3/31/2015	24	-2	N/A	0	N/A
12/31/2014	26	2	N/A	2	N/A
9/30/2014	24	0	N/A	0	N/A
6/30/2014	21	-3	N/A	-3	N/A
3/31/2014	21	-3	N/A	-3	N/A
12/31/2013	20	-3	N/A	-3	N/A

アナリストによる今後の成長予測

収入対貯蓄率: NANの予測収益成長率 (年間24% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: NANの収益 ( 24% ) はAustralian市場 ( 12.6% ) よりも速いペースで成長すると予測されています。

高成長収益: NANの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: NANの収益 ( 8.7% ) Australian市場 ( 5.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: NANの収益 ( 8.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: NANの自己資本利益率は、3年後には低くなると予測されています ( 11.2 %)。

Nanosonics 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Nanosonics Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021

Recent updates

Nanosonics Limited Announces Board Retirements

Nanosonics Limited, Annual General Meeting, Nov 12, 2024

Investor sentiment improves as stock rises 19%

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: AU$0.043 (vs AU$0.066 in FY 2023)

Nanosonics Limited to Report Fiscal Year 2024 Results on Aug 27, 2024

Independent Non-Executive Director recently sold AU$304k worth of stock

New minor risk - Insider selling

Key Executive recently bought AU$100k worth of stock

First half 2024 earnings released: EPS: AU$0.02 (vs AU$0.034 in 1H 2023)

Investor sentiment deteriorates as stock falls 30%

Now 37% undervalued after recent price drop

Nanosonics Limited to Report First Half, 2024 Results on Feb 26, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Nanosonics Limited Announces Appointment of Jason Burriss as Chief Financial Officer, Effective 3 October 2023

Nanosonics Limited Appoints Larry Marshall as Non- Executive Director, Effective from 3 October 2023

Nanosonics Limited, Annual General Meeting, Nov 03, 2023

Full year 2023 earnings released: EPS: AU$0.066 (vs AU$0.012 in FY 2022)

Nanosonics Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Nanosonics Limited Announces the Appointment of Tracey Batten as Non-Executive Director, Effective 26 September 2023

CEO, President recently sold AU$121k worth of stock

Nanosonics Announces Company Secretary Changes

Independent Non-Executive Director recently sold AU$504k worth of stock

First half 2023 earnings released

Nanosonics Limited to Report First Half, 2023 Results on Feb 23, 2023

Insufficient new directors

Insufficient new directors

Now 20% undervalued

CEO, President recently sold AU$960k worth of stock

Full year 2022 earnings released: EPS: AU$0.012 (vs AU$0.029 in FY 2021)

Nanosonics Limited, Annual General Meeting, Nov 18, 2022

Nanosonics Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

Now 21% undervalued after recent price drop

Nanosonics Limited Announces Management Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Nanosonics Limited to Report First Half, 2022 Results on Feb 22, 2022

Full year 2021 earnings released: EPS AU$0.029 (vs AU$0.034 in FY 2020)

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Nanosonics to Launch Digital Platform for Infection Control

First half 2021 earnings released: EPS AU$0.005 (vs AU$0.019 in 1H 2020)

Revenue misses expectations

New 90-day low: AU$6.41

Nanosonics Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$7.85

New 90-day high: AU$6.72

I-MED Signs Agreement with Nanosonics to Upgrade Their Trophon EPR Fleet to Trophon2

Nanosonics Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021

Earnings released

New 90-day low - AU$5.92

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘